23 C
Vientiane
Monday, April 28, 2025
spot_img
Home Blog Page 178

TRON x HTX DAO 2025 Hong Kong Whale Night: Igniting Web3 Momentum & Advancing Global Finance

SINGAPORE, April 9, 2025 /PRNewswire/ — HTX DAO took the spotlight at the “TRON x HTX DAO 2025 Hong Kong Whale Night,” co-hosted with TRON on April 8 alongside the 2025 Hong Kong Web3 Festival. The event gathered industry leaders, institutional innovators, and Web3 pioneers to explore the future of decentralized governance and financial systems.

Justin Sun on TRON, HTX DAO, and the Future of Web3

In a powerful keynote, Justin Sun, Founder of TRON and Global Advisor of HTX, shared his reflections on 13 years of crypto leadership and his vision for the next chapter of Web3. Citing the values of “fear, reverence, and respect”, Sun emphasized long-term commitment over short-term speculation.


“Whether markets rise or fall, we are here to build,” Sun declared. “HTX DAO and TRON will continue to serve as the backbone of decentralized finance, providing clarity, security, and innovation.”

Sun also addressed the industry’s path to global scale, predicting the total digital asset market could eventually reach $200 trillion. “The mission is simple,” he said. “Get the math right. Get the security right. That’s how we earn trust and unlock the next wave of growth.”

HTX DAO Launches Token-Based Governance

Molly, Ambassador of HTX DAO, introduced the launch of the $HTX Token-Weighted Voting Tool, which enables holders to participate in on-chain governance. The feature marks a step toward building a truly community-led exchange.

“This tool makes every $HTX holder a stakeholder in the platform’s future,” Molly said.

She also previewed HTX DAO’s first two governance proposals, including the establishment of a DAO committee and the launch of a community media series, DAO Talk.

HTX Ventures: Regulation and Stablecoins Will Drive 2025 Growth

Alec Goh, Head of HTX Ventures, presented an outlook on the global regulatory landscape, highlighting how recent shifts are unlocking institutional participation. He noted the positive impact of MiCAR in Europe and the crypto-favorable stance of the current U.S. administration.

“The stigma around regulation is changing. Institutions are no longer on the sidelines—they’re deploying capital,” Goh said. He emphasized that stablecoin adoption and regulatory clarity would be the two primary drivers of crypto market growth in 2025.

Crypto Leaders Join the Conversation

Other notable speakers included Jack Kong, Founder of Nano Labs; Ken Zhang, Head of Security of Google Cloud; and Chanel, Contributor of Core. Their insights spanned blockchain security, infrastructure growth, and global developer engagement—reinforcing the evening as a convergence point for thought leadership and collaboration across the Web3 space.

Immersive Web3 Engagements Connect Community and Culture

The event was not only a forum for thought leadership but also an immersive experience for attendees. Highlights included:

  • A Forbes cover-themed photo booth featuring Justin Sun.
  • Trivia quizzes, blind box giveaways, and exclusive challenges.
  • A tremendous prize pool including crypto rewards, VIP black cards, and exclusive merch.

These engaging touchpoints brought Web3 technology and culture closer to users, reinforcing HTX DAO’s mission of building a user-first ecosystem.

From Hong Kong to the World: A New Era of Decentralized Finance

By leveraging Hong Kong’s global financial reach and Web3-friendly environment, HTX DAO is setting new standards for community-driven platforms. Backed by HTX infrastructure and the TRON ecosystem, HTX DAO aims to build a decentralized, transparent, and inclusive financial Freeport for the world.

About HTX DAO
As a multi-chain deployed decentralized autonomous organization (DAO), HTX DAO demonstrates an innovative governance approach. It pioneers a blended CeFi/DeFi paradigm, including listing and community governance, through its focus on building an exchange DAO and a free financial hub ecosystem. Unlike traditional corporate structures, it adopts a decentralized governance structure composed of a diversified group, jointly committed to the success of this organization. This unique ecosystem advocates openness and encourages all DAO participants to propose ideas that can promote the development of HTX DAO.

Website: www.htxdao.co

Robotic Last-Mile Delivery Set to Transform Urban Logistics and Reach US$1.74 Billion in Revenues by 2032

As last-mile delivery costs continue to ramp up, AMRs being cost efficient has enabled continued adoption, especially in high population density urban areas and structured environments

NEW YORK, April 9, 2025 /PRNewswire/ — According to new research from global technology intelligence firm ABI Research, worldwide robotic last-mile delivery revenues are forecasted to grow from US$260 million in 2025 to over US$1.74 billion by 2032. In addition, the total number of robotic deliveries deployed is expected to reach 25,000 by 2032 nearly. Robotic deliveries consist of Autonomous Mobile Robots (AMRs), and their growth is fostering partnerships and investments across the ecosystem. This could address future staffing complexities and growing last-mile delivery costs in urban areas.

High last-mile delivery costs, combined with carriers’ focus on delivery speed, are driving adoption in different regions worldwide. “North America has seen an enormous increase in the number of robotics providers such as Nurov, Cruise, and Starship Technologies, which are driving deployments in the last-mile delivery space. With AMR technology advancing, an increasing number of use cases are being realized in urban zones and structured areas such as malls and universities,” explains Adhish Luitel, Principal Analyst, Supply Chain Management & Logistics at ABI Research.

The online grocery market has also grown substantially, leading to an increase in grocery-based last-mile deliveries focusing on AMRs. The recent partnership between Starship Technologies and Bolt Food in Europe is a good example. The blend of Starship’s cutting-edge robotic technologies and Bolt’s expansion in the market can set the scene for urban last-mile deliveries across Europe. E-commerce penetration in the grocery sector is set to reach 15% by 2026, up from 8.8% in 2020. Globally, e-commerce sales will grow to US$8.1 trillion in 2026.

“AMRs also have the lowest cost-per-delivery and much lower carbon emissions, which has led to continued adoption. They have the lowest cost-per-delivery of any mobility. As deployments ramp up from university to suburbs and city streets, enterprises will be able to judge not only their operational efficiency but also the response from the larger communities and stakeholders as they adjust to sharing their sidewalks, streets, and crosswalks with these efficient machines,” Luitel concludes.

These findings are from ABI Research’s Last-Mile Delivery Solutions market data report. This report is part of the company’s Supply Chain Management and Logistics research service, which includes research, data, and ABI Insights.

About ABI Research

ABI Research is a global technology intelligence firm uniquely positioned at the intersection of technology solution providers and end-market companies. We serve as the bridge that seamlessly connects these two segments by providing exclusive research and expert guidance to drive successful technology implementations and deliver strategies proven to attract and retain customers.

ABI Research是一家全球性的技术情报公司,拥有得天独厚的优势,充当终端市场公司和技术解决方案提供商之间的桥梁,通过提供独家研究和专业性指导,推动成功的技术实施和提供经证明可吸引和留住客户的战略,无缝连接这两大主体。

For more information about ABI Research’s services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific, or visit www.abiresearch.com.

Contact Info:

Global                                                             
Deborah Petrara                                                           
Tel: +1.516.624.2558                                                   
pr@abiresearch.com

XGRIDS Unveils LCC: Pioneering SLAM-Based Gaussian Splatting Software for Rapid, Photorealistic 3D Environment Creation

HONG KONG, April 9, 2025 /PRNewswire/ — XGRIDS LIMITED has officially launched the commercial release of brand new Lixel CyberColor Solution (LCC), following extensive beta testing with industry partners. This enterprise-grade solution combines 3D Gaussian Splatting with multi-SLAM technology to transform spatial data capture, processing, and utilization across multiple industries.

LCC enables organizations to create measurable, interactive, and photorealistic 3D models and digital twins by integrating LiDAR and visual data from Lixel series scanners. These digital environments provide actionable spatial intelligence for improved decision-making and visualization.

“With LCC Studio, we’re democratizing access to advanced spatial computing tools that were previously available only to specialized technical teams,” said Kaiyong Zhao, CEO of XGRIDS.

The platform offers tailored solutions for eight key verticals:

  • Architecture & Construction: Detailed as-built documentation with precise measurement capabilities
  • Real Estate: Immersive virtual property tours with interactive notes and seamless space transitions
  • Industrial Digitization: Comprehensive digital twins for operational efficiency
  • Facility Inspection: Detailed documentation for maintenance planning and compliance
  • Robotics & Embodied AI: Spatial intelligence for navigation and environment recognition
  • Cultural Heritage: High-fidelity preservation and virtual access to historical sites
  • Entertainment & Gaming: Realistic environmental assets for production
  • Education: Immersive learning environments with spatial context

Key Technical Advancements:

  • Rapid Processing: Converts 10 minutes of scanning into detailed 3D models in approximately 100 minutes.
  • Efficient Storage: File sizes up to 88% smaller than traditional methods.
  • Enhanced Accuracy: Advanced measurement tools provide precise spatial data.
  • Map Fusion: Seamless integration of aerial and ground scans into cohesive models.
  • Easy Publishing: Cloud-based management with custom URLs and controlled access.

LCC is available in two tiers:

  • Basic Version with core functionality
  • Premium Version with advanced pro features

“Our pricing structure enables both small studios and large enterprises to leverage this technology for competitive advantage,” explained Sunny Liao, Director of Global Sales at XGRIDS.

All versions are available immediately through XGRIDS’ global distribution network.
For inquiries: enterprise@xgrids.com 

About XGRIDS

XGRIDS is a global leader in SLAM-based 3D scanning and 3D Gaussian Splatting technology, providing solutions for virtual production, architecture, engineering, construction, gaming, and digital twins. The company’s Lixel series scanners and LCC 3D reconstruction technology deliver high-accuracy, measurable 3D models that transform workflows across industries.

Leidos and Moveworks Bring Agentic AI Capabilities to Government Agencies

RESTON, Va., April 9, 2025 /PRNewswire/ — Leidos (NYSE:LDOS), a leading information technology partner for governments worldwide, and Moveworks, the leading agentic artificial intelligence (AI) assistant for enterprises, are collaborating to increase the efficiency of government workers in the U.S., U.K., and Australia.

Agentic AI helps people do their work better and faster as a digital personal assistant that knows how to make decisions and automate daily work processes. As commercial organizations are embracing it, the Leidos-Moveworks partnership will allow government agencies to adopt the technology with assured security and compliance.

“For decades, Leidos has been at the forefront of helping government agencies achieve their mission objectives with speed and precision,” said Steve Hull, president of digital modernization at Leidos. “Our expertise in AI and cybersecurity provides a solid foundation for introducing this transformative technology to the government sector. We’re excited to bring these capabilities to government agencies where rapid, intelligent solutions will bring great benefits.”

Government employees using agentic AI for administrative tasks such as managing computers and mobile phones, navigating databases and drafting emails will have more time to focus on their agencies’ core missions.  

“Collaborating with Leidos allows us to elevate the standard of government employee support,” said Bhavin Shah, CEO and co-founder of Moveworks. “Our focus is on developing AI solutions that enhance the efficiency and quality of operations within government agencies.”

Leidos helped Moveworks achieve U.S. government security certification ready status to work with federal agencies. That ensures Moveworks is equipped to support government agencies with secure and compliant AI solutions.

Learn more about the Leidos and Moveworks partnership.

Learn more about Moveworks’ Government solutions.

About Leidos

Leidos is an industry and technology leader serving government and commercial customers with smarter, more efficient digital and mission innovations. Headquartered in Reston, Virginia, with 48,000 global employees, Leidos reported annual revenues of approximately $16.7 billion for the fiscal year ended January 3, 2025. For more information, visit www.leidos.com.

About Moveworks

Moveworks is the leading agentic AI assistant, helping businesses transform with a single place that empowers the entire workforce. Moveworks enables organizations to boost productivity by streamlining how employees across the company find answers and automate tasks. Currently 350+ large enterprises and over 5 million+ employees rely on Moveworks — including 10% of the Fortune 500. Customers include Hearst, Instacart, Palo Alto Networks, Siemens, Toyota, and Unilever. Moveworks surpassed $100M ARR in September of 2024 and has raised $315 million in funding at a $2.1 billion valuation from investors such as Alkeon, Bain, Iconiq, Kleiner Perkins, Lightspeed, Sapphire, and Tiger Global. The company is based in Mountain View, CA and has offices in Austin, Bangalore, New York, San Francisco, and Toronto. For more information, follow Moveworks on LinkedIn or visit Moveworks.com.

Certain statements in this announcement constitute “forward-looking statements” within the meaning of the rules and regulations of the U.S. Securities and Exchange Commission (SEC). These statements are based on management’s current beliefs and expectations and are subject to significant risks and uncertainties. These statements are not guarantees of future results or occurrences. A number of factors could cause our actual results, performance, achievements, or industry results to be different from the results, performance, or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, the “Risk Factors” set forth in Leidos’ Annual Report on Form 10-K for the fiscal year ended January 3, 2025, and other such filings that Leidos makes with the SEC from time to time. Readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. Leidos does not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statements were made.  

Media Contact:                                                       

Victor Melara
Press Secretary & Senior Media Relations Manager
703.431.4612
victor.a.melara@leidos.com

Logo – https://laotiantimes.com/wp-content/uploads/2025/04/leidos_new_logo.jpg

Infoblox and Google Cloud Announce Partnership to Deliver Cloud-Native Networking and Security Solutions, Reducing Complexity for Enterprise Customers

  • Companies join forces to help drive innovation in both networking and security—simplifying operations while delivering more visibility, control and protection.
  • Infoblox Universal DDI™, the only network services solution providing best-of-breed DNS, DHCP and IPAM services, now integrates with Google’s Cloud WAN, to help ensure maximum performance, simplicity and resiliency.
  • Google Cloud’s new DNS Armor, powered by Infoblox, natively provides robust and preemptive detection of malicious activity for Google Cloud workloads.

SANTA CLARA, Calif., April 9, 2025 /PRNewswire/ — Infoblox, a leader in cloud networking and security services, today announced it is collaborating with Google Cloud to simplify enterprise networking and security while helping organizations accelerate their cloud transformation journeys. Infoblox and Google Cloud are offering two new solutions to help enterprises address challenges in hybrid, multi-cloud networking and cybersecurity:

Infoblox Universal DDI™ for Google’s Cloud WAN is a fully integrated solution that combines the world-class, global Google Cloud Cross-Cloud Network infrastructure with Infoblox’s industry-leading DNS and DHCP capabilities to transform enterprise networking.

Google Cloud DNS Armor, powered by Infoblox, is a next-generation, native Protective DNS solution that provides robust and preemptive detection of malicious activity for Google Cloud workloads.

“The partnership with Google Cloud represents a strategic milestone in our commitment to innovation and mission to enhance cloud networking and security,” said Scott Harrell, president and CEO, Infoblox. “It’s a testament to the critical role that Protective DNS and DDI services play in managing and securing today’s hybrid multi-cloud environments. Infoblox and Google Cloud are providing enterprises with tightly integrated, cloud-first solutions that enable secure connectivity while also reducing operational overhead. Together, our technologies are used to manage critical workloads at nearly every Fortune 100 company.”

“At Google Cloud, we are committed to building a cloud infrastructure with global scale that helps simplify operations for our customers,” said Muninder Singh Sambi, VP/GM, Networking, Google Cloud. “Enabling a resilient and secure network is a critical component of that vision—bridging networking and security to help ensure seamless connectivity and performance. Infoblox has long been a leader in DDI and Protective DNS innovation, making them the ideal partner to help us deliver enterprise-grade network services in the cloud. By integrating Infoblox’s technology into Google Cloud, we’re making it easier for organizations to modernize, connect and scale their global operations with confidence.”

As businesses today face growing challenges to simplify operations, strengthen security and stay agile, they require a more streamlined, integrated approach to networking and security.

“The partnership between Infoblox and Google Cloud marks a major leap forward in enterprise networking and security,” said Alfredo Rodriguez, vice president, cloud platform infrastructure, Sabre Corporation. “By uniting their expertise, they are delivering scalable, intelligent solutions that simplify branch operations, fortify defenses and enable agile, efficient cloud connectivity.”

  • Infoblox Universal DDI for Google’s Cloud WAN

    The Infoblox Universal DDI integration with Google’s Cloud WAN allows organizations to quickly deploy Universal DDI’s NIOS-X as a Service with ease. Infoblox Universal DDI for Google’s Cloud WAN provides infrastructure-free DNS and DHCP services, anywhere in the world, tightly integrated with the Google Cloud Cross-Cloud Network. The combination provides enterprises modernizing their infrastructure with enhanced performance, resiliency and scale across the globe.

    These integrated services greatly simplify infrastructure deployment and management, reducing total cost of ownership while helping to ensure the efficient delivery of applications, workloads and services to branches, data centers and users worldwide. This fully integrated, centrally managed solution unifies enterprise backbones, SD-WANs and enterprise-grade critical network services. And, when combined with Infoblox security offerings, Infoblox Universal DDI can be used as a single interception point to deploy consistent security policies across an entire hybrid cloud infrastructure.

    Infoblox Universal DDI for Google’s Cloud WAN is available in the Google Cloud Marketplace.

  • DNS Armor, powered by Infoblox

    DNS Armor from Google Cloud leverages Infoblox’s deep expertise in protective DNS and DNS-centric threat intelligence to secure cloud workloads, delivering simplified, scalable threat detection. The solution provides enhanced and preemptive security designed to integrate seamlessly without increasing operational complexity. It allows customers to inspect DNS communications for malicious activity, such as ransomware, command and control, data exfiltration, Zero Day DNS threats, domain generation algorithms and more.

    Infoblox’s technology powers the DNS Armor service, and customers can activate and configure DNS threat detection directly on the Google Cloud console. Administrators can monitor DNS queries and access real-time DNS threat logs that enable early threat detection and a proactive security posture. DNS Armor can detect attacks 63 days before other solutions. The solution is easy for any Google Cloud customer to activate within the Google Cloud console.

“As cyber threats grow more sophisticated, the collaboration between Infoblox and Google Cloud delivers a game-changing approach to network security,” said Bob Walker, senior domain network engineer, Lloyds Banking Group. “Google Cloud’s DNS Armor, powered by Infoblox, harnesses the best of both technologies—cutting-edge DNS threat intelligence and scalable cloud architecture—to provide enterprises with robust protection against emerging threats.”

“Infoblox powers Google Cloud’s DNS Armor with intelligence beyond just a DNS block list—tracking activity of potential adversaries to uncover and flag every corner of their malicious network,” said Chris Kissel, research vice president, security and trust, IDC. “The first challenge to cybersecurity is it’s typically reactive, and DNS Armor, powered by Infoblox, provides a preemptive solution to securing cloud workloads that doesn’t add additional complexity or compute.”

For more information on Infoblox and Google Cloud’s partnership, check out the Infoblox Universal DDI for Google’s Cloud WAN launch blog and the Google Cloud DNS Armor, powered by Infoblox launch blog.

About Infoblox
Infoblox unites networking, security and cloud to form a platform for operations that’s as resilient as it is agile. Trusted by 13,000+ customers, including 92 of the Fortune 100, we seamlessly integrate, secure and automate critical network services so businesses can move fast without compromise. Visit infoblox.com, or follow us on LinkedIn.

Media Contact:
Ariel Roop
Head of Global Communications
pr@infoblox.com

Ractigen’s RAG-17 ALS Data Shines at AAN 2025: Earns Top Award, Phase I Advances

  • Final results from an Investigator-Initiated Trial presented for the first time, demonstrating favorable safety, significant target engagement, and encouraging clinical & biomarker signals
  • Abstract honored with prestigious “Abstracts of Distinction” award by AAN Science Committee, recognizing top quality and interest
  • Phase I clinical trial for RAG-17 advancing as planned with dosing successfully completed for the first two cohorts

NANTONG, China and SAN DIEGO, April 9, 2025 /PRNewswire/ — Ractigen Therapeutics, a clinical-stage biopharmaceutical company focused on developing pioneering RNA-based medicines, today announced that the final, positive results from the Investigator-Initiated Trial (IIT) of RAG-17, a novel siRNA therapy targeting SOD1 for Amyotrophic Lateral Sclerosis (ALS), were presented for the first time during an oral presentation at the American Academy of Neurology (AAN) 2025 Annual Meeting in San Diego, CA.

The presentation, titled “RAG-17 a Novel siRNA Therapy for SOD1-ALS: Safety and Preliminary Efficacy from a First-in-human Trial,” was delivered on April 7th by Dr. Weiqi Chen of Beijing Tiantan Hospital, Capital Medical University, on behalf of the team led by the study’s Principal Investigator, Dr. Yilong Wang.

Highlighting the significance and quality of the research, the abstract was selected by the AAN Science Committee for the prestigious “Abstracts of Distinction” award. This honor is awarded to abstracts deemed to be the top in their topic category based on the quality of the study and interest to the neurologic community. This follows Ractigen’s previous announcement in September 2024 regarding the positive initial clinical data obtained from this IIT study.

Key Findings from the RAG-17 IIT Study Presented at AAN 2025:
The final data from the IIT (NCT05903690), a first-in-human, open-label, dose-escalation study involving six SOD1-ALS patients over 240 days, demonstrated:

  • Favorable safety and tolerability: RAG-17 was generally well-tolerated with intrathecal administration. No dose-limiting toxicities (DLTs) or serious adverse events (SAEs) were reported. Most adverse events were mild and transient.
  • Significant target engagement: Treatment with RAG-17 led to a substantial reduction of SOD1 protein levels in the cerebrospinal fluid (CSF), exceeding 50% in five out of six subjects, confirming potent target engagement in the central nervous system.
  • Substantial reduction in key biomarker: Significant reductions in plasma neurofilament light chain (NfL) levels, a key biomarker of neuroaxonal damage, were observed, suggesting a potential impact on neurodegeneration.
  • Encouraging clinical efficacy signals: Patients treated with RAG-17 showed encouraging trends in clinical outcome measures. The average decrease in the ALS Functional Rating Scale-Revised (ALSFRS-R) score was 2.17 points over the study period (equivalent to a 0.29-point decline per month), suggesting potential slowing of functional decline. Forced Vital Capacity (FVC) remained stable in most patients, with two showing a significant increase from baseline.

Phase I Trial Update
Ractigen Therapeutics also reports that a Phase I clinical trial for RAG-17 is progressing smoothly. This randomized, double-blind, placebo-controlled dose escalation study is designed to further evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy in SOD1-ALS patients. Following the first patient dosing announced in December 2024, two cohorts have now successfully completed. The trial is being conducted across multiple sites, led by investigators including Dr. Yilong Wang at Beijing Tiantan Hospital, Dr. Zhiying Wu at the Second Affiliated Hospital of Zhejiang University School of Medicine, and Dr. Huifang Shang at West China Hospital, Sichuan University.

“We are thrilled that our RAG-17 program has been honored with an Abstract of Distinction at the AAN 2025 meeting. This recognition highlights the significance of our work in addressing the unmet needs of SOD1-ALS patients,” said Dr. Long-Cheng Li, President and CEO of Ractigen Therapeutics. “The positive final data from our IIT, demonstrating favorable safety, robust target knockdown, and encouraging biomarker and clinical signals, combined with the ongoing progress in our Phase I trial, reinforce our commitment to bringing this innovative therapy to those who need it most.”

Dr. Yilong Wang, Principal Investigator of the RAG-17 IIT study and Vice President of Beijing Tiantan Hospital, Capital Medical University, commented, “The results presented at AAN 2025 demonstrate the potential of RAG-17 to significantly impact the lives of patients with SOD1-ALS. The safety profile and early efficacy signals, particularly the significant reduction in CSF SOD1 and plasma NfL levels alongside stable functional measures, are encouraging. We look forward to continuing our work in the Phase I study to further validate these findings and bring this therapy closer to clinical application.”

About RAG-17
RAG-17 is an investigational siRNA therapeutic candidate designed using Ractigen’s proprietary SCAD™ delivery platform technology to specifically target and silence the superoxide dismutase 1 (SOD1) gene mRNA. Mutations in the SOD1 gene cause a toxic gain-of-function and are a known cause of familial Amyotrophic Lateral Sclerosis (ALS). By reducing the production of the toxic mutant SOD1 protein, RAG-17 aims to slow or halt the progression of SOD1-ALS.

About ALS
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease affecting nerve cells in the brain and spinal cord, leading to muscle weakness, paralysis, and ultimately death, typically within three to five years of diagnosis. SOD1 gene mutations account for approximately 10-20% of familial ALS cases and about 1-2% of sporadic ALS cases. There remains a critical unmet medical need for effective treatments that can slow or stop disease progression.

About Ractigen Therapeutics 
Ractigen Therapeutics is a clinical-stage biopharmaceutical company innovating next-generation RNA therapeutics, with a primary focus on small activating RNAs (saRNAs) developed through its clinically validated RNA activation (RNAa) technology. Leveraging proprietary delivery platforms such as SCAD™, LiCO™, and GLORY™, Ractigen is advancing a robust pipeline addressing unmet medical needs in oncology, neurological diseases, and genetic disorders. Its versatile technologies also enable the rapid development of RNA-based solutions, including siRNAs, where applicable, to target life-threatening, fast-progressing conditions such as those in the CNS. Committed to scientific excellence and patient-centered innovation, Ractigen strives to transform healthcare through the power of RNA therapeutics. For more information, visit www.ractigen.com.

 

MaintainX Recognized with Frost & Sullivan’s 2025 North American Technology Innovation Leadership Award for Pioneering AI-Powered Maintenance and Asset Optimization in North America

MaintainX empowers frontline teams with innovative AI-powered maintenance tools, real-time asset insights, and seamless integrations that enhance operational efficiency

SAN ANTONIO, April 9, 2025 /PRNewswire/ — Frost & Sullivan recently researched the artificial intelligence (AI)powered asset maintenance and frontline execution platforms market and, based on its findings, recognizes MaintainX with the 2025 North American Technology Innovation Leadership Award. MaintainX is a forward-thinking provider of AI-driven maintenance and operations management solutions that strengthen frontline teams with real-time asset insights, reliable predictive maintenance, and streamlined workflow automation.

MaintainX’s AI-powered platform transforms organizations’ maintenance and asset operations by integrating highly intelligent automation, real-time analytics, and a mobile-first experience. The company’s solution is designed to reduce unplanned downtime, optimize asset utilization, and boost workforce productivity across industries such as manufacturing, facilities, distribution centers and other physical asset driven industries. One of the standout aspects of MaintainX is its superior ability to provide real-time asset availability and parts usage data, allowing frontline professionals to avoid costly stockouts and maintenance delays. Additionally, the platform’s advanced reporting and predictive analytics equip organizations with actionable insights, helping them anticipate equipment failures, optimize inventory management, and drive cost savings.

Another key differentiator is the MaintainX CoPilot, which redefines how organizations access and utilize institutional knowledge. The tool enables technicians and managers to quickly retrieve critical information, standardize procedures, and accelerate operational decision-making. These qualities make MaintainX CoPilot a vital solution for preserving knowledge and ensuring long-term maintenance efficiency and business continuity.

“MaintainX CoPilot is an AI-powered maintenance assistant transforming how teams access and utilize institutional knowledge. By analyzing original equipment manufacturer manuals and work order history, the assistant can help technicians and managers quickly find critical information, create standardized procedures, and get real-time answers to maintenance questions. This purpose-built AI tool goes beyond generic chatbots, making complex technical documentation more accessible and actionable for maintenance teams while helping preserve valuable institutional knowledge as experienced workers transition,” said Sankara Narayanan, industry director at Frost & Sullivan.

The company leverages cutting-edge AI and machine learning (ML) technologies to revolutionize maintenance processes. Its predictive maintenance capabilities allow organizations to detect failures before they occur, drastically reducing downtime and maintenance costs. MaintainX also integrates with IoT sensors and SCADA systems, enabling real-time data collection that significantly enhances asset health and performance visibility.

Moreover, MaintainX simplifies complex maintenance tasks and facilitates digital transformation by harnessing AI-driven automation. Its original AI workflows allow organizations to automate maintenance planning, optimize resource allocation, and standardize best practices across multiple facilities. These intelligent features maximize productivity and ensure that maintenance teams can make data-driven decisions with outstanding speed and accuracy.

“Outside of using data to give customers more visibility about what is happening on their facility floor, MaintainX incorporates AI and ML technologies in its solution to enable customers to simplify and accelerate maintenance. Its Applied AI workflows and predictive maintenance unearth several compelling use cases,” noted Sankara Narayanan.

Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality that is gaining rapid acceptance in the market. The award recognizes the quality of the solution and the customer value enhancements it enables.

“At MaintainX, we’re committed to transforming how organizations approach maintenance and operations through continual innovation. Our platform isn’t just about fixing equipment, it’s about empowering frontline teams with real-time insights and predictive capabilities that drive productivity and extend asset lifecycles. The MaintainX CoPilot represents our vision for the future of maintenance: preserving institutional knowledge, standardizing best practices, and making technical expertise accessible to everyone. We’re honored to receive this recognition from Frost & Sullivan, which validates our approach to solving critical challenges for maintenance teams across industries,” said Hugo Dozois-Caouette, MaintainX CTO and Co-Founder.

Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, megatrends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Contact:

Ashley Shreve
Marketing Coordinator – Best Practices Recognition
Ashley.Weinkauf@frost.com
Phone: +1.210.844.2505

About MaintainX
Headquartered in San Francisco, MaintainX is a technology company pioneering a mobile-first approach to intelligent, software-defined maintenance and operations management. It empowers frontline teams to manage work orders, assets, parts inventory, and purchase orders more efficiently, reducing unexpected downtime and boosting production capacity. MaintainX leverages AI and IIoT to connect asset and work data, providing real-time insights that drive proactive maintenance and operational excellence for 10K+ customers across physical asset-driven industries. MaintainX operates in North America with additional support worldwide. MaintainX is reimagining how maintenance and operations can be designed and managed to address the realities of today and the future ahead. For more information, visit www.maintainx.com.

MaintainX® is a registered trademark of MaintainX Inc.

Contacts
For media inquiries: press@getmaintainx.com

Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology

SEOUL, South Korea, April 9, 2025 /PRNewswire/ — Darnatein, a wholly-owned subsidiary of OSR Holdings, Inc. (NASDAQ: OSRH), today announces that it has successfully secured an additional international patent for its protein-based osteoarthritis treatment technology, marking a significant step in its expansion into the global market.

Activin/BMP7 Chimera Protein Technology Registered in China

Darnatein has officially registered a patent with the China National Intellectual Property Administration (CNIPA) for the core technology behind its break-through disease-modifying osteoarthritis drug (DMOAD) lead drug candidate, DRT-101. Following the national registration of the patent in South Korea in November last year, this marks the company’s first successful international patent registration as part of its efforts to secure global intellectual property rights through the PCT (Patent Cooperation Treaty) route in key regions such as the EU, the United States, and China.

The technology basis is an AI-enhanced innovative protein structure generator designed to provide therapeutics that overcome the current limitations of standard of care treatment in osteoarthritis—a condition for which only symptom management options currently exist. This technology represents a wholly new approach to protein design and is expected to address the underlying causes of disease. This treatment approach may significantly improve treatment outcomes not only for osteoarthritis but also for a wide range of other musculoskeletal disorders.

In particular, the DRT-101 chimeric protein, which recombines the natural BMP7 and Activin proteins into a wholly novel structure, has already been shown to enhance both therapeutic efficacy and safety in vivo, in studies conducted between 2020 and 2024 at the University of California, San Diego, School of Medicine.

Senyon Choe, Darnatein Chief Executive Officer, stated, “The protein design technology now also patented in China has been developed over years from a core platform strategy to the current technology with the potential to revolutionize the global OA treatment market. Securing intellectual property rights in China, one of the largest markets in the world, is a crucial stepping-stone for our global expansion.”

Constance Höfer, Chief Scientific Officer of OSR Holdings, stated, “Darnatein’s groundbreaking technology represents a wholly new, AI-enhanced approach to therapeutic protein design. The successful patent registration in China underscores the novelty and relevance of this technology to the development of better treatment options for OA patients worldwide.”

Global Technological Competitiveness and Licensing Potential

The osteoarthritis treatment market continues to grow, due to globally aging populations. In 2023, the market size reached approximately USD 8.9 billion and is projected to grow at an average annual rate of about 7%, reaching approximately USD 16.1 billion by 2032. China is experiencing rapid population aging and a surge in osteoarthritis cases, making it a highly promising market.

Industry experts have remarked, “Darnatein’s Activin/BMP7 chimera technology offers a superior profile to be developed into a potential DMOAD, or disease-modifying OA drug, compared to existing standard of care for osteoarthritis treatments,” adding, “Big Pharma is looking for novel treatments that can slow, stop, or even reverse the cartilage degeneration and joint damage that occurs with OA. On this backdrop, Darnatein’s chimeric protein approach represents a paradigm shift away from only symptom relief (e.g. painkillers and anti-inflammatories) to treatment options targeting the underlying pathobiology of OA”

Darnatein is currently completing preclinical studies with DRT-101, its degenerative OA treatment candidate, with the goal to initiate Phase 1 clinical trials later this year.

About Darnatein

Founded in 2012, Darnatein is a biotherapeutics company based in South Korea developing a pipeline of innovative treatments for osteoarthritis and bone fusion, including DRT-101 as a ground breaking disease-modifying OA drug (DMOAD) candidate. Darnatein was established by Dr. Senyon Choe, one of the co-founders of the structural protein laboratory of the prestigious Salk Institute for Biological Studies in La Jolla, CA, and a faculty member of UC San Diego since 1993. Darnatein operates as a wholly owned subsidiary of OSR Holdings, Inc. following its acquisition in 2023. 

About OSR Holdings, Inc.

OSR Holdings, Inc. is a global healthcare company dedicated to advancing biomedical innovation. Through its subsidiaries, OSR is engaged in oncology immunotherapies, degenerative disease biologics, and medical device distribution. OSR’s vision is to acquire and operate a portfolio of innovative healthcare companies, improving patient care through cutting-edge research and development. For more information, visit www.OSR-Holdings.com.

Contact

ir@osr-holdings.com